About

Publications While At HealthPartners

selected publications

Journal Article

A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872. 

Cancer. 2019

Contact

full name

T. J. Kaufmann

Quick Info

 

Collaboration

Co-author network

Map of science